A fusion of user
antonyms:  marketer groups led by the Center for Science in the Public Interest and Consumers Union on Tuesday in a letter asked Congress not to intervene in a recent decision by CMS that will limit medicaid coverage for use of anemia medications -- Aranesp, manufactured by Amgen, and Procrit, manufactured by Johnson & Johnson -- in cancer patients, The Hill reports (Young, The Hill, 10/18). [click link for full article]

More: - From the site